
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NEPH market cap is 38.16M. The company's latest EPS is USD 0.0070 and P/E is 514.29.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 3.52M | 3.25M | 3.52M | 3.87M | 4.88M |
Operating Income | -200k | -317k | 206k | 317k | 566k |
Net Income | -169k | -289k | 183k | 349k | 558k |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 8.79M | 10.4M | 9.98M | 14.24M | 14.16M |
Operating Income | -4.28M | -4.34M | -4.34M | -1.59M | 6k |
Net Income | -4.77M | -4.11M | -7.38M | -1.58M | 74k |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 11.42M | 11.1M | 10.39M | 11.21M | 11.78M |
Total Liabilities | 3.24M | 3.17M | 2.21M | 2.63M | 2.49M |
Total Equity | 8.18M | 7.93M | 8.17M | 8.59M | 9.29M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 18.51M | 17.65M | 11M | 11.86M | 11.21M |
Total Liabilities | 2.94M | 2.9M | 2.12M | 3.5M | 2.63M |
Total Equity | 15.57M | 14.75M | 8.88M | 8.36M | 8.59M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -672k | -1.17M | -1.8M | -492k | 322k |
Investing | N/A | -50k | -50k | -50k | N/A |
Financing | -2k | -4k | -4k | -5k | -1,000 |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.9M | -1.42M | -3.23M | 827k | -492k |
Investing | -239k | -85k | -137k | -75k | -50k |
Financing | 11.22M | 237k | 34k | -79k | -5k |
Market Cap | 38.16M |
Price to Earnings Ratio | 514.29 |
Price to Sales Ratio | 2.69 |
Price to Cash Ratio | 10.15 |
Price to Book Ratio | 4.45 |
Dividend Yield | - |
Shares Outstanding | 10.6M |
Average Volume (1 week) | 47.86k |
Average Volume (1 Month) | 66.76k |
52 Week Change | 77.34% |
52 Week High | 5.00 |
52 Week Low | 1.35 |
Spread (Intraday) | 0.14 (3.73%) |
Company Name | Nephros Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.nephros.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions